AnalystsEva Fortea Verdejo
Eva Fortea Verdejo's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 9%
#425 out of 5269 analysts
Average Return
+41.48%
Win Rate
77%27 out of 35
Risk vs Reward
Poor
Good

Eva Fortea Verdejo's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Revolution Medicines IncRVMD
+226.71%$46.24$151.07
2025-09-10 -
2026-05-06
Strong Buy
Arcus Biosciences IncRCUS
+149.19%$8.01$19.96
2025-05-06 -
2026-02-12
Strong Buy
Merus NvMRUS
+127.08%$41.25$93.67
2025-02-06 -
2025-09-29
Strong Buy
Merus NvMRUS
+119.01%$42.77$93.67
2025-05-07 -
2025-09-29
Strong Buy
Arcus Biosciences IncRCUS
+115.09%$9.28$19.96
2025-08-06 -
2026-02-12
Strong Buy

Eva Fortea Verdejo's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Exelixis IncEXEL
2Hold$40.00-17.86%Maintains
a day ago
Kiniksa Pharmaceuticals International PLCKNSA
5Strong Buy$57.00-2.11%Maintains
8 days ago
Relay Therapeutics IncRLAY
5Strong Buy$21.00+62.54%Maintains
9 days ago
Revolution Medicines IncRVMD
3Strong Buy$167.00+10.54%Maintains
23 days ago
Ideaya Biosciences IncIDYA
2Strong Buy$48.00+67.01%Maintains
23 days ago
Bicara Therapeutics IncBCAX
4Hold$16.00-32.72%Maintains
a month ago
Nuvalent IncNUVL
1Strong Buy$116.00+11.26%Initiates Coverage On
a month ago
Sutro Biopharma IncSTRO
1Strong Buy$27.00-28.36%Upgrades
a month ago
Genmab AGMAB
1Strong Buy$40.00+43.42%Initiates Coverage On
2 months ago
Arcus Biosciences IncRCUS
5Hold$23.00-11.54%Downgrades
3 months ago
Zymeworks IncZYME
4Strong Buy$33.00+19.52%Upgrades
5 months ago
Immunocore Holdings PLCIMCR
1Strong Buy$60.00+95.25%Initiates Coverage On
6 months ago
Merus NvMRUS
5Hold$97.00+7.78%Downgrades
7 months ago
Iteos Therapeutics IncITOS
7Hold$11.00+8.37%Maintains
9 months ago
Xencor IncXNCR
3Strong Buy$27.00+107.53%Maintains
9 months ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.